terlipressin has been researched along with Hepatocellular Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Z; Xu, X; Ye, J | 1 |
Choi, JH; Chun, HJ; Hyun, JJ; Jeen, YT; Keum, BR; Kim, CD; Kim, YH; Kim, YS; Lee, HS; Lee, SW; Park, S; Ryu, HS; Seo, YS; Um, SH | 1 |
1 trial(s) available for terlipressin and Hepatocellular Carcinoma
Article | Year |
---|---|
[A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].
Topics: Acute Disease; Aged; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hemostasis, Endoscopic; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Lypressin; Male; Middle Aged; Multivariate Analysis; Somatostatin; Terlipressin; Varicose Veins; Vasoconstrictor Agents | 2006 |
1 other study(ies) available for terlipressin and Hepatocellular Carcinoma
Article | Year |
---|---|
Effects of terlipressin and somatostatin on liver function after major hepatectomy for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Somatostatin; Terlipressin | 2021 |